Advertisement
Journal of Clinical Oncology  
Search for:
Limit by:
  Browse by Subject or Issue
Home Search or Browse JCO Subscriptions PDA Services My JCO Customer Service

Journal of Clinical Oncology, Vol 24, No 20 (July 10), 2006: pp. 3274-3281
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.06.6597

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Save to my personal folders
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Sorensen, A. G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sorensen, A. G.

REVIEW ARTICLE

Magnetic Resonance As a Cancer Imaging Biomarker

A. Gregory Sorensen

From the Athinoula A. Martinos Center for Biomedical Imaging, Department of Radiology, Massachusetts General Hospital, and the Division of Health Sciences and Technology, Harvard Medical School and the Massachusetts Institute of Technology, Boston, MA

Address reprint requests to A. Gregory Sorensen, MD, Building 149, Room 2301, 13th St, Charlestown, MA 02129; e-mail: sorensen{at}nmr.mgh.harvard.edu

Cancer is a diverse disease with many manifestations. Magnetic resonance (MR) has a wide range of sensitivities, and therefore has often been used to study cancer in humans in numerous different ways, most typically with MR spectroscopy and MR imaging. This article is not an exhaustive catalog of the use of MR in cancer, but will briefly highlight some of the many promising MR methods that have been developed, proposed, or used to focus on the problem of detecting and characterizing cancer, its treatments, and adverse effects.

Author's disclosures of potential conflicts of interest are found at the end of this article.




This article has been cited by other articles:


Home page
JCOHome page
D. A. Hamstra, A. Rehemtulla, and B. D. Ross
Diffusion Magnetic Resonance Imaging: A Biomarker for Treatment Response in Oncology
J. Clin. Oncol., September 10, 2007; 25(26): 4104 - 4109.
[Abstract] [Full Text] [PDF]


Home page
CA Cancer J ClinHome page
D. A. Torigian, S. S. Huang, M. Houseni, and A. Alavi
Functional Imaging of Cancer with Emphasis on Molecular Techniques
CA Cancer J Clin, July 1, 2007; 57(4): 206 - 224.
[Abstract] [Full Text] [PDF]


Home page
RadiologyHome page
R. L. Ehman, W. R. Hendee, M. J. Welch, N. R. Dunnick, L. B. Bresolin, R. L. Arenson, S. Baum, H. Hricak, and J. H. Thrall
Blueprint for Imaging in Biomedical Research
Radiology, July 1, 2007; 244(1): 12 - 27.
[Full Text] [PDF]



About
JCO
 Editorial
Roster
 Advertising
Information
 Librarians &
Institutions
 Rights &
Permissions
 Site Map

Copyright © 2006 by the American Society of Clinical Oncology, Online ISSN: 1527-7755. Print ISSN: 0732-183X
Terms and Conditions of Use
  HighWire Press HighWire Press™ assists in the publication of JCO Online